Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

GSK3β overexpression indicates poor prognosis and its inhibition reduces cell proliferation and survival of non-small cell lung cancer cells.

Zeng J, Liu D, Qiu Z, Huang Y, Chen B, Wang L, Xu H, Huang N, Liu L, Li W.

PLoS One. 2014 Mar 11;9(3):e91231. doi: 10.1371/journal.pone.0091231. eCollection 2014.

2.

The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.

Liu XH, Liu ZL, Sun M, Liu J, Wang ZX, De W.

BMC Cancer. 2013 Oct 8;13:464. doi: 10.1186/1471-2407-13-464.

3.

Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.

Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu WQ, Xie WP, Hou YY.

BMC Cancer. 2013 Oct 7;13:461. doi: 10.1186/1471-2407-13-461.

4.

Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.

Sun M, Liu XH, Wang KM, Nie FQ, Kong R, Yang JS, Xia R, Xu TP, Jin FY, Liu ZJ, Chen JF, Zhang EB, De W, Wang ZX.

Mol Cancer. 2014 Mar 21;13:68. doi: 10.1186/1476-4598-13-68.

5.

DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.

Wang Z, Luo Z, Zhou L, Li X, Jiang T, Fu E.

Cancer Sci. 2015 Oct;106(10):1303-12. doi: 10.1111/cas.12755. Epub 2015 Sep 3.

6.

Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.

Yang Y, Meng H, Peng Q, Yang X, Gan R, Zhao L, Chen Z, Lu J, Meng QH.

Cancer Gene Ther. 2015 Jan;22(1):23-9. doi: 10.1038/cgt.2014.66. Epub 2014 Dec 5.

PMID:
25477028
7.

MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.

Yang J, Lan H, Huang X, Liu B, Tong Y.

PLoS One. 2012;7(8):e42978. doi: 10.1371/journal.pone.0042978. Epub 2012 Aug 10.

8.

microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.

Huang J, Sun C, Wang S, He Q, Li D.

Mol Biosyst. 2015 Jul;11(7):2051-9. doi: 10.1039/c4mb00752b.

PMID:
25988292
9.

Prognostic significance of twist and N-cadherin expression in NSCLC.

Hui L, Zhang S, Dong X, Tian D, Cui Z, Qiu X.

PLoS One. 2013 Apr 23;8(4):e62171. doi: 10.1371/journal.pone.0062171. Print 2013.

10.

Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.

Zhang K, Li Y, Liu W, Gao X, Zhang K.

Mol Med Rep. 2015 Jan;11(1):639-44. doi: 10.3892/mmr.2014.2729. Epub 2014 Oct 21.

PMID:
25333812
11.

Decreased microRNA-132 and its function in human non-small cell lung cancer.

Liu X, Yan S, Pei C, Cui Y.

Mol Med Rep. 2015 May;11(5):3601-8. doi: 10.3892/mmr.2015.3222. Epub 2015 Jan 19.

PMID:
25607827
12.

Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.

Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS, Feng XJ.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):6929-35. eCollection 2014.

13.
14.

Role of the stem cell-associated intermediate filament nestin in malignant proliferation of non-small cell lung cancer.

Chen Z, Wang J, Cai L, Zhong B, Luo H, Hao Y, Yu W, Wang B, Su C, Lei Y, Bella AE, Xiang AP, Wang T.

PLoS One. 2014 Feb 3;9(2):e85584. doi: 10.1371/journal.pone.0085584. eCollection 2014.

15.

Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.

Miao Y, Wang L, Zhang X, Xu X, Jiang G, Fan C, Liu Y, Lin X, Yu J, Zhang Y, Wang E.

PLoS One. 2014 Nov 14;9(11):e112258. doi: 10.1371/journal.pone.0112258. eCollection 2014.

16.

ADAM17 silencing suppresses the migration and invasion of non-small cell lung cancer.

Lv X, Li Y, Qian M, Ma C, Jing H, Wen Z, Qian D.

Mol Med Rep. 2014 May;9(5):1935-40. doi: 10.3892/mmr.2014.2029. Epub 2014 Mar 7.

PMID:
24626788
17.

Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.

Chen X, Song X, Yue W, Chen D, Yu J, Yao Z, Zhang L.

Oncotarget. 2015 Jun 20;6(17):15022-34.

18.

ZFX knockdown inhibits growth and migration of non-small cell lung carcinoma cell line H1299.

Li K, Zhu ZC, Liu YJ, Liu JW, Wang HT, Xiong ZQ, Shen X, Hu ZL, Zheng J.

Int J Clin Exp Pathol. 2013 Sep 15;6(11):2460-7. eCollection 2013.

19.

Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.

Grbesa I, Pajares MJ, Martínez-Terroba E, Agorreta J, Mikecin AM, Larráyoz M, Idoate MA, Gall-Troselj K, Pio R, Montuenga LM.

PLoS One. 2015 Apr 27;10(4):e0124670. doi: 10.1371/journal.pone.0124670. eCollection 2015.

20.

Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.

Zhang S, Wang Y, Dai SD, Wang EH.

BMC Cancer. 2011 May 20;11:186. doi: 10.1186/1471-2407-11-186.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk